Thrap3 promotes nonalcoholic fatty liver disease by suppressing AMPK-mediated autophagy
Cited 0 times inCited 0 times in
- Thrap3 promotes nonalcoholic fatty liver disease by suppressing AMPK-mediated autophagy
- Jang, Hyun-Jun; Lee, Yo Han; Tam, Dao; Jo, Yunju; Khim, Keon Woo; Eom, Hye-jin; Lee, Ju Eun; Song, Yi Jin; Choi, Sun Sil; Park, Kieun; Ji, Haneul; Chae, Young Chan; Myung, Kyungjae; Kim, Hongtae; Ryu, Dongryeol; Park, Neung Hwa; Park, Sung Ho; Choi, Jang Hyun
- Issue Date
- EXPERIMENTAL AND MOLECULAR MEDICINE, v.55, pp.1720 - 1733
- Autophagy functions in cellular quality control and metabolic regulation. Dysregulation of autophagy is one of the major pathogenic factors contributing to the progression of nonalcoholic fatty liver disease (NAFLD). Autophagy is involved in the breakdown of intracellular lipids and the maintenance of healthy mitochondria in NAFLD. However, the mechanisms underlying autophagy dysregulation in NAFLD remain unclear. Here, we demonstrate that the hepatic expression level of Thrap3 was significantly increased in NAFLD conditions. Liver-specific Thrap3 knockout improved lipid accumulation and metabolic properties in a high-fat diet (HFD)-induced NAFLD model. Furthermore, Thrap3 deficiency enhanced autophagy and mitochondrial function. Interestingly, Thrap3 knockout increased the cytosolic translocation of AMPK from the nucleus and enhanced its activation through physical interaction. The translocation of AMPK was regulated by direct binding with AMPK and the C-terminal domain of Thrap3. Our results indicate a role for Thrap3 in NAFLD progression and suggest that Thrap3 is a potential target for NAFLD treatment.
- Appears in Collections:
- BIO_Journal Papers
- Files in This Item:
- There are no files associated with this item.
can give you direct access to the published full text of this article. (UNISTARs only)
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.